Public Health Experts Explore Ways To Better Integrate NCD Treatment Into Health Systems

Devex: An emerging strategy to tackle chronic disease
“… ‘Where we are now on NCDs is not far from where we were 20 years ago on communicable diseases,’ Isabelle Torres, global head of access to medicines at Takeda Pharmaceutical Co., told Devex at an event hosted by the company in Geneva to bring together government, NGO, and private sector leaders to discuss a roadmap for NCDs. Public health experts described an emerging consensus around actionable steps that can help countries and that the global health community can take to address this evolving reality. Tackling NCDs will require policy adjustments, reformed health system structures, and effective partnerships that break down silos…” (Saldinger, 7/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.